Clinical trial
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study, Comparing Tretinoin Gel Microsphere, 0.04% (Sun Pharmaceutical Industries, Inc.) and RETIN-A MICRO ® (Tretinoin) Gel Microsphere, 0.04% (Reference Listed Drug) in the Treatment of Acne Vulgaris.
NCT07469228 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study, Comparing Tretinoin Gel Microsphere, 0.04% (Sun Pharmaceutical Industries, Inc.) and RETIN-A MICRO ® (Tretinoin) Gel Microsphere, 0.04% (Reference Listed Drug) in the Treatment of Acne Vulgaris.
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 4, 2025
- Completion date
- December 15, 2025
- Enrollment
- 1,043 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.